Table 5.
Predicted PEth sensitivity for each variable calculated from the regression models, holding all others at their means. Categories for continuous variables are the midpoints of categories defined in Table 4.
| Predictors | Model 1 | Model 2 | Model 3 |
|---|---|---|---|
| AUDIT-C score | |||
| Medium: 4 | 77.1% (68.5–85.6) | 82.5% (76.4–88.6) | 78.9% (70.9–86.9) |
| High: 6 | 84.8% (78.1–91.5) | 88.2% (83.0–93.4) | 83.5% (77.4–89.5) |
| Very high: 10 | 90.9% (86.2–95.5) | 92.1% (88.2–96.1) | 88.2% (84.0–92.3) |
| Sex | |||
| Male | 86.3% (79.8–92.8) | 88.8% (83.8–93.9) | 84.4% (78.8–89.9) |
| Female | 84.6% (77.5–91.8) | 89.5% (84.1–94.9) | 85.7% (79.3–92.0) |
| Race/ethnicity | |||
| African | 90.2% (81.9–98.6) | 93.2% (87.9–98.4) | 91.5% (82.2–100.8) |
| African American | 84.1% (77.1–91.1) | 87.7% (81.3–94.0) | 84.3% (78.2–90.5) |
| White | 80.7% (72.1–89.4) | 82.6% (73.4–91.8) | 76.8% (66.9–86.8) |
| Other | 82.7% (73.7–91.7) | 83.9% (74.8–93.0) | 79.8% (66.9–92.7) |
| Age | |||
| 20 | 78.4% (68.5–88.2) | 79.0% (67.6–90.5) | 83.0% (67.7–98.3) |
| 30 | 83.3% (76.9–89.8) | 85.9% (80.1–91.7) | 84.2% (75.7–92.8) |
| 40 | 86.0% (79.5–92.5) | 89.0% (83.9–94.0) | 84.7% (78.9–90.5) |
| 50 | 86.9% (80.0–93.8) | 89.7% (84.5–95.0) | 84.4% (78.9–89.9) |
| 60 | 86.4% (79.2–93.5) | 88.6% (83.2–93.9) | 83.3% (77.6–89.1) |
| Method of blood collection | |||
| Finger-prick | 86.6% (73.7–99.4) | ||
| Venous blood collection | 85.7% (79.2–92.2) | ||
| Body mass index (kg/m2) | |||
| Underweight: 17.5 | 92.3% (88.4–96.1) | 89.3% (84.2–94.3) | |
| Normal: 22 | 90.3% (85.8–94.9) | 86.5% (81.2–91.9) | |
| Overweight: 27.5 | 87.1% (81.1–93.0) | 82.1% (76.2–87.9) | |
| Obese: 33 | 83.2% (75.2–91.2) | 76.8% (70.1–83.6) | |
| Hemoglobin (g/dL) | |||
| Moderate/severe: 10 | 82.0% (74.1–89.8) | 74.9% (66.4–83.4) | |
| Mild anemia: 11.5 | 84.8% (78.2–91.5) | 78.9% (71.8–86.0) | |
| No anemia: 14 | 88.8% (83.7–94.0) | 84.5% (78.9–90.1) | |
| High hemoglobin: 17.5 | 92.9% (89.0–96.8) | 90.3% (85.6–95.0) | |
| HIV status | |||
| Negative | 90.9% (86.4–95.5) | 87.1% (81.5–92.7) | |
| Positive | 88.6% (83.4–93.8) | 84.3% (78.7–89.9) | |
| FIB-4 score | |||
| No/mild fibrosis: <1.45 | 83.1% (77.3–88.8) | ||
| 1.45–3.25 | 86.1% (80.2–92.1) | ||
| Advanced fibrosis: >3.25 | 89.8% (84.8–94.8) |